Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Taipei
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

OBI Pharma Inc

+ Add to Watchlist

4174:TT

337.50 TWD 3.50 1.03%

As of 02:31:46 ET on 06/02/2015.

Snapshot for OBI Pharma Inc (4174)

Open: 339.00 Day's Range: 337.50 - 343.50 Volume: 527,035
Previous Close: 341.00 52wk Range: 288.00 - 455.00 1-Yr Rtn: +5.63%

Stock Chart for 4174

No chart data available.
  • 4174:TT 337.50
  • 1D
  • 1M
  • 1Y
341.00
Interactive 4174 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4174

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. TWOTCI -
Earnings Per Share (TWD) (ttm) -4.4600
Est. EPS (TWD) (12/2015) -4.8230
Est. PEG Ratio -
Market Cap (M TWD) 57,596.54
Shares Outstanding (M) 170.66
30 Day Average Volume 837,722
Price/Book (mrq) 35.0607
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4174

  • Revenue
  • Net Income (M/TWD)
  • Profit Margin (%)

Company Profile & Key Executives for 4174

OBI Pharma Inc manufactures anti-infective and immunotherapy drugs and develops cancer and infectious disease therapies.

Chang Nian-TzuChairman/FounderHsu Yu-KungVice Chairman/Chief Planner
Huang Hsiu-MeiPresidentYu Cheng-TeChief R&D Officer
More Company Profile & Key Executives for 4174

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil